Parkinson's Disease and Allied Conditions - Original Article

Journal of Neural Transmission

, Volume 116, Issue 2, pp 151-160

DJ-1 protects against dopamine toxicity

  • Nirit LevAffiliated withLaboratory of Neuroscience, Department of Neurology, Felsenstein Medical Research Centre, Rabin Medical Centre, Tel Aviv University Email author 
  • , Debby IckowiczAffiliated withLaboratory of Neuroscience, Department of Neurology, Felsenstein Medical Research Centre, Rabin Medical Centre, Tel Aviv University
  • , Yael BarhumAffiliated withLaboratory of Neuroscience, Department of Neurology, Felsenstein Medical Research Centre, Rabin Medical Centre, Tel Aviv University
  • , Shaul LevAffiliated withLaboratory of Neuroscience, Department of Neurology, Felsenstein Medical Research Centre, Rabin Medical Centre, Tel Aviv University
  • , Eldad MelamedAffiliated withLaboratory of Neuroscience, Department of Neurology, Felsenstein Medical Research Centre, Rabin Medical Centre, Tel Aviv University
  • , Daniel OffenAffiliated withLaboratory of Neuroscience, Department of Neurology, Felsenstein Medical Research Centre, Rabin Medical Centre, Tel Aviv University

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Parkinson’s disease (PD) is a slowly progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons. Dopamine is a highly toxic compound leading to generation of reactive oxygen species (ROS). DJ-1 mutations lead to early-onset inherited PD. Here, we show that DJ-1 protects against dopamine toxicity. Dopamine-exposure led to upregulation of DJ-1. Overexpression of DJ-1 increased cell resistance to dopamine toxicity and reduced intracellular ROS. Contrary effects were achieved when DJ-1 levels were reduced by siRNA. Similarly, in vivo striatal administration of 6-hydroxydopamine led to upregulation of DJ-1. Upregulation of DJ-1 was mediated by the MAP kinases pathway through activation of ERK 1, 2 in vitro and in vivo. Hence, oxidative stress, generated by free cytoplasmic dopamine, leads to upregulation of DJ-1 through the MAP kinases pathway. This mechanism elucidates how mutations in DJ-1 prompt PD and imply that modulation of DJ-1 may serve as a novel neuroprotective modality.

Keywords

Dopamine DJ-1 Parkinson’s disease Oxidative stress MAP kinases